恆科指數跌幅擴至4.2% 惟閱文及平安好醫生逆升逾9%及4%
納指繼昨晚急挫2.6%為三個月來最傷後,在季績勝預期蘋果股價盤後仍續吐3.3%拖累,期貨續跌0.8%報13,003。本港恆指科技指數由紀錄高位連跌第三天,且跌幅擴至4.2%報9,397即市低位。
30隻科技成份股普遍跌逾2%-4%。ASM(00552.HK)更急挫9%報110.4元;中芯(00981.HK)、微盟(02013.HK)、華虹半導體(01347.HK)及丘鈦科技(01478.HK)也挫8%-8.5%,分別報26.8元、21.65元、44.8元及16.02元。
金山軟件(03888.HK)、舜宇(02382.HK)、京東集團(09618.HK)、阿里健康(00241.HK)及京東健康(06618.HK)跌逾5.5%-7%。
不過,夥百度等公司入股內地上市的「中文在線」成為策略投資者的閱文(00772.HK)逆市高見81.7元創逾兩年半高,現造70.5元,逆市續升9.6%。此外,先後獲摩通及匯豐重申「增持」及「買入」評級分別看122元及115元的平安好醫生(01833.HK)曾一舉升破百天線及牛熊線(98.05元及98.74元),最高見103.5元,現造98.55元,續升4.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.